Sofinnova Investments, Inc.

CIK 0001631134 · Q2 2026

13F Equity AUM

$1.9B

-26.5% QoQ

Positions

-69 QoQ

AUM Rank

#2,374

Top 19%

Skill Alpha (FF)

+16.3%/yr^ns

No Clear Edge

Rank #144 · Top 2%

vs S&P +7.4%/yr (unadj.)

Quarters Tracked

~8 years

Portfolio Concentration

Top 5: 42.4%Top 10: 58.8%Top 20: 79.6%

NTRA21.8%

VERA6.2%

GMAB5.7%

JAZZ4.5%

RAPP4.1%

Seaport Therapeutics Inc4.0%

RARE3.8%

AVBP3.0%

BIOA2.9%

BMY2.6%

Others (46)41.3%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

No sector data available.

Position Sizing

Positions: 56Median: 0.88%Avg: 1.79%

0–0.5%

17(1.9%)

0.5–1%

13(9.5%)

1–3%

18(35.4%)

3–5%

5(19.5%)

5%+

3(33.7%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 56vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New0Increased0Decreased0Exited0

No position changes this quarter.

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...